21h
New Vision on MSNHIV testing kits with tampered expiry dates recovered in NDA operationTen suspects were arrested on Saturday (March 15) in a sweeping operation conducted by the National Drug Authority (NDA) in Kampala, during which government drugs and tampered-with diagnostic kits ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results